Home › Companies › Foghorn Therapeutics Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Foghorn Therapeutics Inc.’s Form 8-K, filed June 24, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 24, 2026: 3 items on Foghorn Therapeutics Inc.’s Form 8-K, filed June 24, 2026: 3 elected.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2025-2026
Explore Foghorn Therapeutics Inc. in the interactive database Compare manager voting policies
These tallies are Foghorn Therapeutics Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Douglas Cole, M.D. | 35,118,798 | 10,987,092 | 5,562 | -- | 5,597,444 | 76% | Elected | — |
| Elect Director: Simba Gill, Ph.D. | 45,956,872 | 151,145 | 3,435 | -- | 5,597,444 | 99.6% | Elected | — |
| Elect Director: B. Lynne Parshall | 44,412,258 | 1,695,530 | 3,664 | -- | 5,597,444 | 96% | Elected | — |
Source: Foghorn Therapeutics Inc., Form 8-K, filed with the SEC on June 24, 2026 — read the filing on EDGAR.
Each item below shows how the 114 asset managers that disclosed a Foghorn Therapeutics Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Foghorn Therapeutics Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Elect Class III directors each for a three-year term: B. Lynne Parshall
Foghorn Therapeutics Inc.’s own tally for this item (“Elect Director: B. Lynne Parshall”): 44,412,258 for, 1,695,530 against, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders of the Company elected each of the following director nominees to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 7,223,735 for, 242,154 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,935,922 | 0 | 0 | 0 | For |
| Vanguard | 1,729,823 | 4,597 | 0 | 0 | For |
| BlackRock | 1,169,164 | 0 | 0 | 0 | For |
| Charles Schwab | 103,502 | 0 | 0 | 0 | For |
| Equitable | 55,881 | 19,140 | 0 | 0 | Mixed |
| BRIDGEWAY FUNDS INC | 0 | 68,000 | 0 | 0 | Against |
| TIAA | 0 | 49,073 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 43,623 | 0 | 0 | 0 | For |
| Nationwide | 7,437 | 32,624 | 0 | 0 | Mixed |
| Columbia Threadneedle | 28,105 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,548 | 0 | 0 | 0 | For |
| Northern Trust | 25,133 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,000 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 16,607 | 0 | 0 | Against |
| Global X | 15,048 | 0 | 0 | 0 | For |
| Pacific Life | 13,626 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 13,584 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 0 | 12,480 | 0 | 0 | Against |
| State Street | 11,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,778 | 0 | 0 | 0 | For |
| Invesco | 8,130 | 0 | 0 | 0 | For |
| ProShares | 0 | 7,658 | 0 | 0 | Against |
| Voya | 6,490 | 0 | 0 | 0 | For |
| DWS | 0 | 5,062 | 0 | 0 | Against |
| T. Rowe Price | 4,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Elect Class III directors each for a three-year term: Balkrishan (Simba) Gill, Ph.D.
Foghorn Therapeutics Inc.’s own tally for this item (“Elect Director: Simba Gill, Ph.D.”): 45,956,872 for, 151,145 against, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders of the Company elected each of the following director nominees to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 7,443,488 for, 22,402 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,935,922 | 0 | 0 | 0 | For |
| Vanguard | 1,731,339 | 3,082 | 0 | 0 | For |
| BlackRock | 1,169,164 | 0 | 0 | 0 | For |
| Charles Schwab | 103,502 | 0 | 0 | 0 | For |
| Equitable | 55,881 | 19,140 | 0 | 0 | Mixed |
| BRIDGEWAY FUNDS INC | 68,000 | 0 | 0 | 0 | For |
| TIAA | 49,073 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,623 | 0 | 0 | 0 | For |
| Nationwide | 40,061 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 28,105 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,548 | 0 | 0 | 0 | For |
| Northern Trust | 25,133 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,000 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,607 | 0 | 0 | 0 | For |
| Global X | 15,048 | 0 | 0 | 0 | For |
| Pacific Life | 13,626 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 13,584 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 12,480 | 0 | 0 | 0 | For |
| State Street | 11,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,778 | 0 | 0 | 0 | For |
| Invesco | 8,130 | 0 | 0 | 0 | For |
| ProShares | 7,658 | 0 | 0 | 0 | For |
| Voya | 6,490 | 0 | 0 | 0 | For |
| DWS | 5,062 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 4 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: Elect Class III directors each for a three-year term: Douglas Cole, M.D.
Foghorn Therapeutics Inc.’s own tally for this item (“Elect Director: Douglas Cole, M.D.”): 35,118,798 for, 10,987,092 against, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders of the Company elected each of the following director nominees to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal.”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 2,491,791 for, 4,974,098 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 722,040 | 3,213,882 | 0 | 0 | Mixed |
| Vanguard | 1,729,805 | 4,615 | 0 | 0 | For |
| BlackRock | 0 | 1,169,164 | 0 | 0 | Against |
| Charles Schwab | 0 | 103,502 | 0 | 0 | Against |
| Equitable | 0 | 75,021 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 68,000 | 0 | 0 | Against |
| TIAA | 0 | 49,073 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 43,623 | 0 | 0 | Against |
| Nationwide | 0 | 40,061 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 28,105 | 0 | 0 | Against |
| Goldman Sachs | 27,548 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 25,133 | 0 | 0 | Against |
| Lincoln Financial | 0 | 20,000 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 16,607 | 0 | 0 | Against |
| Global X | 0 | 15,048 | 0 | 0 | Against |
| Pacific Life | 0 | 13,626 | 0 | 0 | Against |
| CLEARWATER INVESTMENT TRUST | 0 | 13,584 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 0 | 12,480 | 0 | 0 | Against |
| State Street | 0 | 11,060 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 10,778 | 0 | 0 | Against |
| Invesco | 8,130 | 0 | 0 | 0 | For |
| ProShares | 0 | 7,658 | 0 | 0 | Against |
| Voya | 0 | 6,490 | 0 | 0 | Against |
| DWS | 0 | 5,062 | 0 | 0 | Against |
| T. Rowe Price | 4,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,935,922 | 0 | 0 | 0 | For |
| Vanguard | 1,734,420 | 1 | 0 | 0 | For |
| BlackRock | 1,169,164 | 0 | 0 | 0 | For |
| Charles Schwab | 103,502 | 0 | 0 | 0 | For |
| Equitable | 75,021 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 68,000 | 0 | 0 | Against |
| TIAA | 49,073 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,623 | 0 | 0 | 0 | For |
| Nationwide | 40,061 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 28,105 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,548 | 0 | 0 | 0 | For |
| Northern Trust | 25,133 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,000 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,607 | 0 | 0 | 0 | For |
| Global X | 15,048 | 0 | 0 | 0 | For |
| Pacific Life | 13,626 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 12,480 | 0 | 0 | 0 | For |
| State Street | 11,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,778 | 0 | 0 | 0 | For |
| Invesco | 0 | 8,130 | 0 | 0 | Against |
| ProShares | 7,658 | 0 | 0 | 0 | For |
| Voya | 6,490 | 0 | 0 | 0 | For |
| DWS | 5,062 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,268 | 0 | 0 | 0 | For |
| SEI | 4,200 | 0 | 0 | 0 | For |
Fund voting reports, all 36 managers: 7,376,175 for, 76,131 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,938,877 | 0 | 0 | 0 | For |
| BVF INC/IL | 5,842,000 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4,394,367 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 849,481 | 0 | 0 | 0 | For |
| BlackRock | 821,636 | 890 | 0 | 0 | For |
| Siren, L.L.C. | 712,794 | 0 | 0 | 0 | For |
| State Street | 563,963 | 702 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 313,765 | 0 | 0 | Against |
| AMERIPRISE FINANCIAL INC | 255,755 | 0 | 0 | 0 | For |
| Vanguard | 255,121 | 0 | 0 | 0 | For |
| Northern Trust | 240,011 | 0 | 0 | 0 | For |
| SCS Capital Management LLC | 113,736 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 111,859 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 109,846 | 0 | 0 | 0 | For |
| Charles Schwab | 103,524 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 92,932 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 74,600 | 0 | 0 | Against |
| STATE OF WISCONSIN INVESTMENT BOARD | 66,563 | 0 | 0 | 0 | For |
| Nuveen | 50,394 | 0 | 0 | 0 | For |
| T. Rowe Price | 48,956 | 0 | 0 | 0 | For |
| Renaissance | 43,053 | 0 | 0 | 0 | For |
| Goldman Sachs | 39,660 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 28,813 | 0 | 0 | 0 | For |
| AllianceBernstein | 26,660 | 0 | 0 | 0 | For |
| CANADA PENSION PLAN INVESTMENT BOARD | 25,100 | 0 | 0 | 0 | For |
Institutional-manager reports, all 89 managers: 20,964,068 for, 413,094 against, 7,843 1 year. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF FOGHORN'S NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| DWS | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 36 managers: 2,600 for, 7,449,642 1 year, 64 unknown. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BVF INC/IL | 0 | 0 | 0 | 0 | -- |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Candriam S.C.A. | 0 | 0 | 0 | 0 | -- |
| AMERIPRISE FINANCIAL INC | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| SCS Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| DAFNA Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| STATE OF WISCONSIN INVESTMENT BOARD | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| CANADA PENSION PLAN INVESTMENT BOARD | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 89 managers: 7,714 for, 140 against, 21,377,151 1 year. Showing the 25 largest; see all in the interactive database.
100% of fund votes cast · no official result
Description as filed by funds: TO RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
The 36 asset managers below reported 7,452,306 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,935,922 | 0 | 0 | 0 | For |
| Vanguard | 1,734,421 | 0 | 0 | 0 | For |
| BlackRock | 1,169,164 | 0 | 0 | 0 | For |
| Charles Schwab | 103,502 | 0 | 0 | 0 | For |
| Equitable | 75,021 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 68,000 | 0 | 0 | 0 | For |
| TIAA | 49,073 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,623 | 0 | 0 | 0 | For |
| Nationwide | 40,061 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 28,105 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,548 | 0 | 0 | 0 | For |
| Northern Trust | 25,133 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,000 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,607 | 0 | 0 | 0 | For |
| Global X | 15,048 | 0 | 0 | 0 | For |
| Pacific Life | 13,626 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 12,480 | 0 | 0 | 0 | For |
| State Street | 11,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,778 | 0 | 0 | 0 | For |
| Invesco | 8,130 | 0 | 0 | 0 | For |
| ProShares | 7,658 | 0 | 0 | 0 | For |
| Voya | 6,490 | 0 | 0 | 0 | For |
| DWS | 5,062 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,268 | 0 | 0 | 0 | For |
| SEI | 4,200 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 58,713,922 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 6.70% |
| 2 | Vanguard | 2.95% |
| 3 | BlackRock | 1.99% |
| 4 | Charles Schwab | 0.18% |
| 5 | Equitable | 0.13% |
| 6 | BRIDGEWAY FUNDS INC | 0.12% |
| 7 | TIAA | 0.08% |
| 8 | QUANTITATIVE MASTER SERIES LLC | 0.07% |
| 9 | Nationwide | 0.07% |
| 10 | Columbia Threadneedle | 0.05% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 10.11% |
| 2 | BVF INC/IL | 9.95% |
| 3 | DEERFIELD MANAGEMENT COMPANY, L.P. | 7.48% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 1.45% |
| 5 | BlackRock | 1.40% |
| 6 | Siren, L.L.C. | 1.21% |
| 7 | State Street | 0.96% |
| 8 | Candriam S.C.A. | 0.53% |
| 9 | AMERIPRISE FINANCIAL INC | 0.44% |
| 10 | Vanguard | 0.43% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Noubar Afeyan | 35.38% | 13D |
| Funds affiliated with Flagship Pioneering, Inc. | 29.20% | DEF14A |
| Entities affiliated with Fidelity Investments | 10.96% | DEF14A |
| Entities affiliated with Biotechnology Value Fund | 10.38% | DEF14A |
| FMR (Fidelity) | 10.30% | 13F |
| BVF PARTNERS L P/IL | 9.99% | 13G |
| Deerfield Mgmt, L.P. | 8.75% | 13G |
| Eli Lilly and Company | 6.81% | DEF14A |
| Deerfield Partners LP | 6.27% | DEF14A |
| Cigall Kadoch, Ph.D. | 6.22% | DEF14A |
Percentages above are of 58,713,922 shares outstanding, as reported by Foghorn Therapeutics Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Foghorn Therapeutics Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At Foghorn Therapeutics Inc.'s shareholder meeting held June 24, 2026, in the 2025-2026 proxy season, 114 asset managers reported how they voted in their SEC Form N-PX filings, covering 882 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Foghorn Therapeutics Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF FOGHORN'S NAMED EXECUTIVE OFFICERS. — the reporting funds and managers cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Foghorn Therapeutics Inc. proxy season coverage: 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.